Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-07-26

FDA Approved: EXEMESTANE — Original Application (Upsher-Smith Laboratories, Inc.)

View source ↗

Summary

FDA approved Upsher-Smith's generic exemestane through an original ANDA, expanding access to this aromatase inhibitor. The product is used in the treatment of b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exemestane (Exemestane)

Snippet

ORIG AP for EXEMESTANE (EXEMESTANE)